RecruitingPhase 3ACTRN12605000581662
PRACTICAL TRIAL
Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increase after Coronary intervention in Acute coronary Lesions
Sponsor
Cardiology Dept, Royal Perth Hospital
Enrollment
370 participants
Start Date
Jan 1, 2004
Study Type
Interventional
Conditions
Summary
A multi-centre, randomised, double-blind, clinical trial comparing a 600mg versus 300mg loading dose of Clopidogrel on the Incidence of Myonecrosis and Laboratory Measures of Platelet Inhibition following early Percutaneous Coronary Intervention in Acute Coronary Syndrome patients.
Eligibility
Sex: Both males and females
Inclusion Criteria1
- abnormal electrocardiogram 2. evidence of myonecrosis (elevated troponin I or T above ULN) at presentation.3. known coronary artery disease with previous MI, PCI, CABG surgery, or positive stress test.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Clopidogrel Loading Dose 300mg vs 600mg
Clopidogrel Loading Dose 300mg vs 600mg
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000581662
Related Trials
Oregano and Basil Leaves and Coronary Artery Disease
NCT071231811 location
Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease
NCT075882951 location
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
NCT075828351 location
Point-of-Care Troponin Testing in the Emergency Department
NCT068458261 location
A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices
NCT068900131 location